fondation Innovative Medicines for Tuberculosis (iM4TB)

Commercial register

• • Trade registry entry:

  • 29.01.2014

• • Registered office:

  • 1024 Ecublens VD

• • HR number:

  • CH-550.1.143.053-2

• • UID:

  • CHE-270.892.523

• • CR office:

  • Canton Vaud

• • Statutory auditor:

  • BDO SA

• • SOGC publications:

  • Show commercial register publications

Management & staff

• • Authorised signatories:

  • Show authorised signatories

Financial matters

• • Credit check:

  • Find out about the credit standing, creditworthiness and payment capacity of fondation Innovative Medicines for Tuberculosis (iM4TB) here.

    Check creditworthiness

• • Debt-collection report:

  • We do not yet have a debt enforcement report.

    Would you like to know whether any debt enforcements have been recorded for the company fondation Innovative Medicines for Tuberculosis (iM4TB)? We will gladly obtain an up-to-date report from the responsible debt enforcement office – you can order the report here.

    Order a debt enforcement report

• • Risk report:

  • Would you like all info at a glance? The risk report for fondation Innovative Medicines for Tuberculosis (iM4TB) combines the creditworthiness, score, real payment histories and a debt enforcement excerpt in one report.

    Employee numbers on aktuelle Firma are available for MitarbeiterzahlenJahre.

    We have turnover figures on aktuelle Firma for UmsatzzahlenJahre.

    Risk report

• • Creditworthiness certificate:

  • Companies that have had high creditworthiness for several years can have this confirmed with a document.

    Creditworthiness certificate

Company names & contact

• • Current company name:

  • fondation Innovative Medicines for Tuberculosis (iM4TB)

• • Current address:

  • EPFL Innovation Park

    1015 Lausanne

• • Former names:

  • Fondation Innovative Medicines for Tuberculosis (iM4TB) (to 04.03.2021)

    fondation Innovative Medicines for Tuberculosis (iM4TB) (to 02.04.2014)

• • More contact information

Activity

• • Purpose of company:

  • Les buts principaux de la fondation sont: promouvoir et soutenir la recherche et le développement de médicaments contre la tuberculose et d'autres maladies similaires négligées liées à la pauvreté, telles que la lèpre ou l'ulcère de Buruli; coordonner le projet européen MM4TB initié le 1er février 2011 ainsi que tout projet similaire relatif à la recherche et au développement de médicaments contre la tuberculose et d'autres maladies similaires négligées liées à la pauvreté, telles que la lèpre ou l'ulcère de Buruli. Les fondateurs se réservent expressément la possibilité de faire modifier le but par l'autorité de surveillance, en application de l'article 86a CC.

• • Branch office(s):

  • Other research and experimental development on natural sciences and engineering

• • NOGA 2008:

  • 721900

News

Vicinity

• • Building:

  • Show companies registered at the same address

• • Street:

  • Show companies registered on the same street

• • Town/city:

  • Show companies registered in the same town/city

Company verification badge

Edit entry

• Edit entry

• Do you have any additions or corrections for our data?

  Edit entry